Clinical Trials Sponsored by Nouvelle Société Française d'Athérosclérose
Total 1 results
-
Hotel Dieu de France HospitalPfizer; Nouvelle Société Française d'AthéroscléroseCompletedDyslipidemia in Patients With Diabetes MellitusLebanon
Sponsors and Collaborators
- AMTC & Associates
- University Medical Center Goettingen
- CRMBM-CEMEREM
- Victor Montori
- San MediTech(Huzhou)Co.,Ltd.
- ProteoSys AG
- The Fifth Affiliated Hospital of Zunyi Medical College
- Rui-hua Xu, MD, PhD
- Norsk Proteinintolerance, Norway
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Donders Institute for Brain, Cognition and Behavior
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Fondren Orthopedic Group L.L.P.
- Cardresearch
- Celtaxsys Aus Pty Limited
- Caritas Freetown
- Alberta Children's Hospital, Calgary, Canada
- Societa Italiana di Endoscopia Digestiva
- Elim Pediatric Pharmaceuticals Inc.
- Diego Hernan Giunta, MD
- View Full List
Medical Conditions
- Orbital Tumor
- Fever, Sweats, and Hot Flashes
- Tube Disorders Eustachian
- Stereotactic Radioablation for Ventricular Tachycardia
- Normal Diameter of Optic Nerve
- Prostate Cancer Recurrent
- Lymphedema of Arm
- Atrial Fibrillation, Postoperative
- Non-compressible Torso Hemorrhage
- Fibromyalgia Syndrome, Primary
- Malignant Ascites Due to Epithelial Carcinoma
- Tularaemia
- Plasmodium Falciparum Malaria (Drug Resistant)
- Auditory Hallucination, Verbal
- Non-dystrophic Myotonias
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Disturbance of Activity and Attention
- Spermatogenesis Arrest
- Gynecologic Cancer
- Postcomatose Unawareness State
- View Full List
Drug Interventions
- Methotrexate
- Mupirocin Calcium
- Flibanserin 100 mg dose every evening
- Lamivudine
- Topotecan
- Oxycodone, fentanyl
- Polyethylene glycol 3350
- Indoximod
- Ruxolitinib
- Insulin
- SERETIDE Diskus
- Bortezomib/dexamethasone
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- PF-00868554
- Enzalutamide, Abiraterone
- Cetrorelix 78 mg + 78 mg
- Epimedium Prenylflavonoids Extract
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Atezolizumab
- Cytarabine ARA-C
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Australia
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Qatar
- Contract Research Organizations in Romania
- Contract Research Organizations in Russia
- Contract Research Organizations in South Africa
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Uganda
- Contract Research Organizations in Ukraine
- CRO list by country